Update On Josh Hardy After Getting Drug At St. Jude
(Memphis) A 7-year-old boy at St. Jude has received an experimental drug his doctors and patients hope will save his life.
Today we were told Josh Hardy received the drug, brincidofovir just before 9 Wednesday night.
Hardy will receive several doses of the antiviral drug for an infection from which he is suffering, and be monitored closely.
Doctors treating the child say that while he is very ill, he may be allowed to go outside for a short time this afternoon.
Doctors told us today he used an intravenous version of the drug before but it can damage his kidneys which are already in bad shape.
Josh has survived cancer four times in his short life.
Brincidofovir is not approved by the FDA but is being used under a special protocol.